Adherence to topical microbicides and oral pre-exposure prophylactic HIV preventative treatments: what are the barriers and how are they addressed? Muchomba Felix Muchiri Daudi author Columbia University. Social Work Gearing Robin E. author Columbia University. Social Work El-Bassel Nabila author Columbia University. Social Work Columbia University. Global Health Research Center of Central Asia originator text Presentations 2012 The HIV prevention field has made progress in the use of oral pre-exposure prophylaxis (PrEP) and topical microbicides.1 For preventive treatments to be effective, adherence to intervention protocols is required.2 However, adherence to oral PrEP and microbicides has not been sufficiently studied and recommendations on promoting adherence are needed. This systematic review sought to identify: 1) how adherence was measured; 2) barriers to adherence; and 3) strategies used to promote adherence to these HIV preventative treatments. Presented at the XIX International AIDS Conference, Washington, D.C., July 22-27, 2012. Public health Epidemiology </titleInfo> </relatedItem> <relatedItem> <location> <url/> </location> </relatedItem> <identifier type="hdl">http://hdl.handle.net/10022/AC:P:14234</identifier> <language> <languageTerm type="text">English</languageTerm> </language> <location> <physicalLocation authority="marcorg">NNC</physicalLocation> </location> <recordInfo> <recordContentSource authority="marcorg">NNC</recordContentSource> <recordCreationDate encoding="w3cdtf">2012-07-25 15:41:23 -0400</recordCreationDate> <recordChangeDate encoding="w3cdtf">2012-08-03 12:31:58 -0400</recordChangeDate> <recordIdentifier>8240</recordIdentifier> <languageOfCataloging> <languageTerm authority="iso639-2b">eng</languageTerm> </languageOfCataloging> </recordInfo> </mods>